OIMU
RMD icon

Osmosis Investment Management UK’s ResMed RMD Stock Holding History

Osmosis Investment Management UK’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Buy
11,081
+263
+2% +$54.5K 0.1% 172
2026
Q1 		$2.43M Buy
10,818
+3,341
+45% +$833K 0.07% 226
2025
Q4 		$1.8M Buy
+7,477
New +$1.91M 0.05% 256

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Osmosis Investment Management UK's RMD Position: Q2 2026 in Review

Osmosis Investment Management UK increased its ResMed (RMD) stake by 2.4% in Q2 2026, buying an estimated $54.5K and bringing the position to 11,081 shares worth $2.16M. The position accounts for 0.1% of the portfolio, ranked #172.

Osmosis Investment Management UK first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.43M in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Osmosis Investment Management UK held 11,081 shares of ResMed worth $2.16M as of Q2 2026.
  • Osmosis Investment Management UK bought 263 ResMed shares in Q2 2026, an estimated $54.5K.
  • ResMed made up 0.1% of Osmosis Investment Management UK's portfolio in Q2 2026, its #172 holding.
  • Osmosis Investment Management UK first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's ResMed position peaked at $2.43M in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.